NeOnc Technologies Holdings, Inc. (NTHI) stock
NTHINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 0/30
$4.16−0.17 (-3.93%)
Close on Nov 18, 2026Market cap $107.90MP/E –Yield –
NeOnc Technologies r&d expenses
Research and development expenses are spending on new products and technology.
NeOnc Technologies's R&D Expenses for the twelve months ending Sep 30, 2026 was $6.53M, up 88.2% year over year. For fiscal 2025 it was $3.64M, up 19.5% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.64M | +19.5% |
| FY2024 | Dec 31, 2024 | $3.05M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.31M | +82.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.65M | +291.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.29M | +28.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.29M | +19.3% |
| Q3 FY2025 | Sep 30, 2025 | $715.04K | -25.3% |
| Q2 FY2025 | Jun 30, 2025 | $677.33K | +71.7% |
| Q1 FY2025 | Mar 31, 2025 | $998.22K | +62.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.08M | – |
| Q3 FY2024 | Sep 30, 2024 | $956.73K | – |
| Q2 FY2024 | Jun 30, 2024 | $394.48K | – |
| Q1 FY2024 | Mar 31, 2024 | $614.52K | – |
See a number that looks wrong?